These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 17338725)
1. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Swerdlow CD; Shehata M; Chen PS Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725 [TBL] [Abstract][Full Text] [Related]
2. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329 [TBL] [Abstract][Full Text] [Related]
3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
4. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation. Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181 [TBL] [Abstract][Full Text] [Related]
5. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms. Swerdlow C; Shivkumar K; Zhang J Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611 [TBL] [Abstract][Full Text] [Related]
7. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm. Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143 [TBL] [Abstract][Full Text] [Related]
8. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518 [TBL] [Abstract][Full Text] [Related]
9. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing. Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181 [TBL] [Abstract][Full Text] [Related]
10. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol. Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T; Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789 [TBL] [Abstract][Full Text] [Related]
11. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions. Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924 [TBL] [Abstract][Full Text] [Related]
13. Estimating defibrillation efficacy using combined upper limit of vulnerability and defibrillation testing. Malkin RA; Pilkington TC; Ideker RE IEEE Trans Biomed Eng; 1996 Jan; 43(1):69-78. PubMed ID: 8567007 [TBL] [Abstract][Full Text] [Related]
14. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks. Gunderson BD; Abeyratne AI; Olson WH; Swerdlow CD Pacing Clin Electrophysiol; 2007 Feb; 30(2):157-65. PubMed ID: 17338710 [TBL] [Abstract][Full Text] [Related]
15. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator. Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846 [TBL] [Abstract][Full Text] [Related]
16. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation? Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811 [TBL] [Abstract][Full Text] [Related]
17. Assessment of adequate safety margin using single coupling interval-upper limit of vulnerability test. Patel MB; Pandya K; Thakur RK Pacing Clin Electrophysiol; 2014 Jan; 37(1):95-103. PubMed ID: 24033830 [TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval. Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143 [TBL] [Abstract][Full Text] [Related]
19. Optimal strength and number of shocks at upper limit of vulnerability testing required to predict high defibrillation threshold without inducing ventricular fibrillation. Takami K; Yoshida A; Fukuzawa K; Takei A; Kiuchi K; Kanda G; Kumagai H; Takami M; Torii-Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Nakanishi T; Yamashita S; Matsumoto A; Hirata K Circ J; 2013; 77(10):2490-6. PubMed ID: 23877733 [TBL] [Abstract][Full Text] [Related]
20. Reducing ICD Test Shocks with a Simplified Upper Limit of Vulnerability. Pittaro M; Deforge W; Kroll MW Pacing Clin Electrophysiol; 2016 Jul; 39(7):652-7. PubMed ID: 27019321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]